Moderate Dose of Lipopolysaccharide Induces Tumor Necrosis Factor-alpha and Interleukin-6 Production by Human Monocyte-derived Macrophages
DOI:
https://doi.org/10.3889/oamjms.2021.6453Keywords:
Lipopolysaccharides, Monocytes, Macrophages, Tumor necrosis factor-alpha, Interleukin-6Abstract
BACKGROUND: Macrophages have been widely used for in vitro studies. Despite different types and doses of stimulatory agents that have been tested, there is no consensus for the method.
AIM: This study was aimed to determine a sufficient dose of lipopolysaccharide (LPS) to stimulate inflammatory response in macrophages.
METHODS: Whole blood was collected from four donors after written informed consent. The monocytes were isolated from peripheral blood mononuclear cells and stimulated with macrophage colony-stimulating factor, LPS, and Interferon-gamma for 6 days until differentiated into macrophages. The production of Tumor necrosis factor-alpha (TNF-α) and Interleukin-6 (IL-6) were quantified after 24-h further stimulation with 100 ng/mL and 2 μg/mL of LPS.
RESULTS: Both doses increased TNF-α _production compare to their controls, but not statistically different (p > 0.05). There were also no differences in IL-6 production between treatments, 56.55 ± 32.30 pg/mL and 70.96 ± 65.08 pg/mL, respectively.
CONCLUSION: A dose of 100 ng/mL of LPS was sufficient to stimulate inflammatory response in human monocyte-derived macrophages. A 24-h duration of macrophage stimulation was sufficient to observed the production TNF-α.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Ushio A, Arakaki R, Yamada A, Saito M, Tsunematsu T, Kudo Y, et al. Crucial roles of macrophages in the pathogenesis of autoimmune disease. World J Immunol. 2017;7:1-8. https://doi.org/10.5411/wji.v7.i1.1 DOI: https://doi.org/10.5411/wji.v7.i1.1
Navegantes K, Gomes R, Pereira P, Czaikoski P, Azevedo C, Monteiro M. Immune modulation of some autoimmune diseases: The critical role of macrophages and neutrophils in the innate and adaptive immunity. J Transl Med. 2017;15(1):36. https://doi.org/10.1186/s12967-017-1141-8 PMid:28202039 DOI: https://doi.org/10.1186/s12967-017-1141-8
Rossol M, Heine H, Meusch U, Quandt D, Klein C, Sweet M, et al. LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol. 2011;31(5):379-446. https://doi.org/10.1615/critrevimmunol.v31.i5.20 PMid:22142165 DOI: https://doi.org/10.1615/CritRevImmunol.v31.i5.20
Hirayama D, Iida T, Nakase H. The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis. Int J Mol Sci. 2018;19(1):1-14. https://doi.org/10.3390/ijms19010092 PMid:29286292 DOI: https://doi.org/10.3390/ijms19010092
Fröhlich E. Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo. Int J Nanomed. 2015;10:3761-78. https://doi.org/10.2147/ijn.s83068 PMid:26060398 DOI: https://doi.org/10.2147/IJN.S83068
Dehus O, Hartung T, Hermann C. Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay. J Endotoxin Res. 2006;12(3):171-80. https://doi.org/10.1177/09680519060120030401 PMid:16719988 DOI: https://doi.org/10.1177/09680519060120030401
Schildberger A, Rossmanith E, Eichhorn T, Strassl K, Weber V. Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide. Mediators Inflamm. 2013;2013:697972. https://doi.org/10.1155/2013/697972 PMid:23818743 DOI: https://doi.org/10.1155/2013/697972
Figueroa L, Abarca-Vargas R, Alanis C, Petricevich V. Comparison between peritoneal macrophage activation by Bougainvillea xbuttiana extract and LPS and/or interleukins. Biomed Res Int. 2017;2017:4602952. https://doi.org/10.1155/2017/4602952 PMid:29279849 DOI: https://doi.org/10.1155/2017/4602952
Harte A, Varma M, Tripathi G, McGee K, Al-Daghri N, Al-Attas O, et al. High fat intake leads to acute postprandial exposure to circulating endotoxin in Type 2 diabetic subjects. Diabetes Care. 2012;35(2):375-82. https://doi.org/10.2337/dc11-1593 PMid:22210577 DOI: https://doi.org/10.2337/dc11-1593
Marshall J, Walker P, Foster D, Harris D, Ribeiro M, Paice J, et al. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit Care. 2002;6(4):342-8. PMid:12225611
Tucureanu M, Rebleanu D, Constantinescu C, Deleanu M, Voicu G, Butoi E, et al. Lipopolysaccharide-induced inflammation in monocytes/macrophages is blocked by liposomal delivery of G i-protein inhibitor. Int J Nanomed. 2018;13:63-76. https://doi.org/10.2147/ijn.s150918 PMid:29317816 DOI: https://doi.org/10.2147/IJN.S150918
Borzecka K, Plociennikowska A, Björkelund H, Sobota A, Kwiatkowska K. CD14 mediates binding of high doses of LPS but is dispensable for TNF-α _production. Mediators Inflamm. 2013;2013:824919. https://doi.org/10.1155/2013/824919 PMid:24489448 DOI: https://doi.org/10.1155/2013/824919
Honda T, Inagawa H. Usefulness of monocyte/macrophages activated with low-dose lipopolysaccharide in tumor tissue and adipose tissue of obesity. Anticancer Res. 2019;39(8):4475-8. https://doi.org/10.21873/anticanres.13621 PMid:31366547 DOI: https://doi.org/10.21873/anticanres.13621
Seshadri S, Kannan Y, Mitra S, Parker-barnes J, Wewers MD, Seshadri S, et al. MAIL regulates human monocyte IL-6 production. J Immunol. 2009;183(8):5358-68. https://doi.org/10.4049/jimmunol.0802736 PMid:19783680 DOI: https://doi.org/10.4049/jimmunol.0802736
Wallner S, Schröder C, Leitão E, Berulava T, Haak C, Beißer D, et al. Epigenetic dynamics of monocytetomacrophage differentiation. Epigenetics Chromatin. 2016;9:33. https://doi.org/10.4049/jimmunol.0802736 PMid:27478504 DOI: https://doi.org/10.1186/s13072-016-0079-z
Downloads
Published
How to Cite
License
Copyright (c) 2021 Nuraiza Meutia, Lokot Donna Lubis, Eka Roina Megawati (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
Funding data
-
Universitas Sumatera Utara
Grant numbers 4167/UN5.1.R/PPM